AirSculpt Technologies, Inc.
HealthcareNASDAQ:AIRS · NASDAQ Global Market
+$0.00 today
Vol 0.67M · Avg 2.80M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-13.3%
avg -4.7%
ROIC
-1.9%
avg 0.2%
ROA
-6.2%
avg -1.6%
Analysis
ROIC is currently the strongest return metric at -1.9% versus its period average of 0.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Yogesh Jashnani | Chief Executive Officer & Director | $1.07M | — | 44 | $696,475.00 | 0.99% |
Michael J. Arthur | Chief Financial Officer | $509,532.00 | — | 38 | $215,086.00 | 0.30% |
Brent R. Wadman | General Counsel | — | — | 54 | $55,272.00 | 0.08% |
Stephanie Evans Greene | Chief Marketing Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
16
$2.01M
Sells
1
$13,094.00
Net Sentiment
+$2.00M
Net buying
Most Active
Chernett Jorey
17 transactions
1–10 of 17
Analysis
Insiders reported 16 buys worth $2.01M and 1 sells worth $13,094.00 over the last 12 months. That adds up to net buying of $2.00M. Chernett Jorey was the most active insider with 17 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +46.1% | -3.7% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | -1.9% | -27.2% (5yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at +46.1% over three years. Forward estimates point to Revenue at -3.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
MoonLake Immunotherapeutics
NASDAQ:MLTX
$1.38B
InnovAge Holding Corp.
NASDAQ:INNV
$1.24B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
SI-BONE, Inc.
NASDAQ:SIBN
$683.87M
Community Health Systems, Inc.
NYSE:CYH
$439.66M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$414.11M
Pacific Biosciences of California, Inc.
NASDAQ:PACB
$406.89M
Orthofix Medical Inc.
NASDAQ:OFIX
$376.33M
DarioHealth Corp.
NASDAQ:DRIO
$51.63M
Who manages AIRS?
AirSculpt Technologies, Inc. (AIRS) lists 4 active executives. The top listed executive is Brent R. Wadman, General Counsel.
Are AIRS insiders buying or selling?
Recent insider activity shows net buying of $3.47M.
Explore More
Continue the stock analysis
Jump to another research area for this company.